Applied Dna Sciences Inc (NASDAQ:BNBX – Get Free Report) was the recipient of a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 173,283 shares, an increase of 213.0% from the June 15th total of 55,360 shares. Currently, 2.6% of the shares of the company are short sold. Based on an average trading volume of 271,228 shares, the days-to-cover ratio is currently 0.6 days.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Applied Dna Sciences in a research report on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Applied Dna Sciences currently has an average rating of “Sell”.
Read Our Latest Stock Report on BNBX
Applied Dna Sciences Price Performance
Applied Dna Sciences (NASDAQ:BNBX – Get Free Report) last released its quarterly earnings data on Friday, May 15th. The company reported ($0.68) earnings per share for the quarter. The business had revenue of $1.02 million during the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative return on equity of 349.95%.
About Applied Dna Sciences
Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.
Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.
Further Reading
- Five stocks we like better than Applied Dna Sciences
- China’s Helium Ban Could Reshape the AI Supply Chain
- Analysts See Major Upside for These 5 Stocks
- AMD’s 5C Deal Positions It as a Direct NVIDIA Rival
- AST SpaceMobile’s Next Launches Could Decide Whether Its Rally Regains Orbit
Receive News & Ratings for Applied Dna Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Dna Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
